id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-V-0275-0005,FDA,FDA-2015-V-0275,Variance Approval from FDA CDRH  to Intel Corporation,Other,Approval for Variance (VRA),2016-06-13T04:00:00Z,2016,6,2016-06-13T04:00:00Z,,2016-06-13T18:38:22Z,,0,0,090000648201d739